Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO — Stella

Recruiting

Back to Breast Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Netherlands

NKI-AVL, Amsterdam

Key details

Phase

Safety & dosing

Sponsor

The Netherlands Cancer Institute

Collaborators

Bristol-Myers Squibb

Enrollment target

~80 participants

Started

October 2019

Primary completion

January 2031

Age range

18 Years and older

Sex

Female only

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov